NasdaqGS - Delayed Quote USD

Mannatech, Incorporated (MTEX)

8.20 -0.15 (-1.74%)
At close: April 17 at 4:00 PM EDT
Loading Chart for MTEX
DELL
  • Previous Close 8.35
  • Open 8.20
  • Bid --
  • Ask --
  • Day's Range 8.20 - 8.20
  • 52 Week Range 7.50 - 15.10
  • Volume 89
  • Avg. Volume 908
  • Market Cap (intraday) 15.455M
  • Beta (5Y Monthly) 1.19
  • PE Ratio (TTM) --
  • EPS (TTM) -1.20
  • Earnings Date May 10, 2024 - May 14, 2024
  • Forward Dividend & Yield 0.80 (9.76%)
  • Ex-Dividend Date Jun 14, 2023
  • 1y Target Est --

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.

www.mannatech.com

213

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MTEX

Performance Overview: MTEX

Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MTEX
1.23%
S&P 500
5.06%

1-Year Return

MTEX
44.13%
S&P 500
20.71%

3-Year Return

MTEX
51.77%
S&P 500
19.73%

5-Year Return

MTEX
37.31%
S&P 500
72.77%

Compare To: MTEX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MTEX

Valuation Measures

As of 4/18/2024
  • Market Cap

    15.46M

  • Enterprise Value

    13.45M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.12

  • Price/Book (mrq)

    1.47

  • Enterprise Value/Revenue

    0.10

  • Enterprise Value/EBITDA

    20.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.70%

  • Return on Assets (ttm)

    -1.28%

  • Return on Equity (ttm)

    -18.16%

  • Revenue (ttm)

    131.96M

  • Net Income Avi to Common (ttm)

    -2.24M

  • Diluted EPS (ttm)

    -1.20

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.73M

  • Total Debt/Equity (mrq)

    54.44%

  • Levered Free Cash Flow (ttm)

    -2.48M

Research Analysis: MTEX

Analyst Price Targets

 

Fair Value

Overvalued
% Return
8.20 Current
 

People Also Watch